While Big Pharma bets billions on addictive opioids, iovera is freezing nerves to stop pain at the source. This isn't a pill—it's a device that uses extreme cold to temporarily shut down pain signals, offering immediate relief for up to 90 days. It’s a bold, drug-free approach to a multi-billion dollar problem.

"iovera isn't treating symptoms; it's literally freezing the pain pathway. That's not innovation—it's a disruption."

The tech stack is surprisingly modern for a medical device company. They utilize Tailwind CSS and Bootstrap for rapid frontend development, Swiper for UI interactions, and PWA capabilities for mobile accessibility. However, the reliance on jQuery suggests legacy codebases still in play. The presence of OneTrust indicates compliance with strict healthcare privacy standards (HIPAA/GDPR), a non-negotiable in this space.

• Cryoneurolysis Mechanism: Uses extreme cold to temporarily disrupt nerve function, stopping pain signals before they reach the brain.
• FDA-Cleared & Drug-Free: Positions itself as a safe alternative to opioids, targeting knee, hip, shoulder, and spine pain.
• 90-Day Relief Window: The 'up to 90 days' claim is a critical differentiator, offering a longer duration than most injectable non-opioids.